Pulsenmore (PLSM) Net Income towards Common Stockholders (2025)
Pulsenmore (PLSM) reported Net Income towards Common Stockholders of $0.77 for Q4 2025.
Pulsenmore (PLSM) Net Income towards Common Stockholders (2025) Analysis & Trends
Pulsenmore (PLSM) has 1 years of Net Income towards Common Stockholders data on file, last reported at $0.77 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.75 Bn | 176.46 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 129.05 Bn | 126.17 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 108.57 Bn | 99.35 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 68.61 Bn | 67.16 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 48.41 Bn | 44.74 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.35 Bn | 27.23 Bn | 750.30 Mn | 199.50 Mn |
| 7 | GE HealthCare Technologies | 28.12 Bn | 25.83 Bn | 1.98 Bn | 411.00 Mn |
| 8 | Smith & Nephew | 26.91 Bn | 26.33 Bn | - | - |
| 9 | Koninklijke Philips | 24.26 Bn | 21.14 Bn | 2.07 Bn | 176.78 Mn |
| 10 | Pulsenmore | 21.20 Mn | -475,526.64 | - | 0.77 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 0.77 |